A court appeal by Bayer against India’s first ever compulsory licence on its patented cancer drug will start today, October 29.
The governor of California, Jerry Brown, has refused to sign legislation seeking to introduce changes to the state’s pharmacy law on biosimilars.
Mr Justice Arnold has refused to recuse himself from a patent trial after he was accused of being conflicted by an expert witness.
The US District Court for the District of Arizona has rejected technology company W.L. Gore’s motion for a new trial to amend the judgment of its patent dispute with medical device maker C.R. Bard.
British barrister Richard Hacon is set to become the permanent presiding judge of the Intellectual Property Enterprise Court, multiple sources have told WIPR.
UK-based pharmaceutical company AstraZeneca announced on October 15 that its biologics R&D subsidiary MedImmune had acquired cancer drug maker Spirogen.
Patent litigator Jonathan Radcliffe has left Mayer Brown to become partner at Charles Russell LLP.
The US Court of Appeals for the Federal Circuit has denied a US company’s bid to trademark “Prevail” for medical devices used to treat obesity.
Bayer has appealed against the IPAB’s compulsory licence order that allows domestic generic maker Natco Pharma to market its own version of liver and kidney cancer drug Nexavar, this time at the Mumbai High Court.
After 39 years at the firm, IP litigator Trevor Cook will be leaving UK-based Bird & Bird LLP to join Wilmer Cutler Pickering Hale and Dorr LLP in New York.